Expertise in
18
conditions

Dr. Jamie N. Bakkum-Gamez

Obstetrics and Gynecology
MN - Cancer
200 1st St SW, 
Rochester, MN 
Clinical Trials:Currently Recruiting for 1 Trial
Accepting New Patients
Offers Telehealth
Expertise in
18
conditions
MN - Cancer
200 1st St SW, 
Rochester, MN 

Overview

Jamie Bakkum-Gamez is an Obstetrics and Gynecologist practicing medicine in Rochester, Minnesota.

Dr. Bakkum-Gamez is highly rated in 18 conditions, according to our data. Her clinical expertise encompasses Endometrial Cancer, Ovarian Cancer, Vulvar Cancer, Hysterectomy, and Vulvectomy.

She is actively involved in clinical research, co-authoring 197 peer reviewed articles and participating in 10 clinical trials. Dr. Bakkum-Gamez is currently accepting new patients.

Specialties

Obstetrics and Gynecology

Licenses

Obstetrics & Gynecology in MN

Hospital Affiliations

Mayo Clinic Health System Eau Claire Hospital
Mayo Clinic Hospital Rochester

Languages Spoken

English

Gender

Female

Insurance

Accepted insurance can change. Please verify directly with the provider.

Find your insurance
Find your insuranceClose

Accepted insurance plans:

Blue Cross Blue Shield
  • EPO
  • HMO
  • POS
  • PPO
Cigna
  • EPO
  • HMO
  • PPO
HealthPartners
  • POS
  • PPO
Horizon Healthcare
  • EPO
  • POS
Humana
  • HMO
  • INDEMNITY
  • POS
  • PPO
Medica
  • EPO
  • HMO
  • PPO
Northern Plains Alliance
  • INSURANCE PLAN
  • MANAGED MEDICAID PLAN
  • MEDICARE PDP
South Country Health Alliance
  • INSURANCE PLAN
  • MANAGED MEDICAID PLAN
  • MEDICARE MAPD
  • MEDICARE PDP
UnitedHealthcare
  • EPO
  • HMO
  • POS
  • PPO
Wellcare
  • EPO
  • HMO
  • INSURANCE PLAN
  • MANAGED MEDICAID PLAN
  • MEDICARE MAPD
  • MEDICARE PDP
  • MEDICARE SNP
  • MEDICARE-MEDICAID PLAN
  • OTHER MEDICARE
  • OTHER MEDICARE PART D
View 5 Less Insurance Carriers -

Locations

MN - Cancer
200 1st St SW, Rochester, MN 55905

Clinical Research

Clinical research consists of overseeing clinical studies of patients undergoing new treatments and therapies, and publishing articles in peer reviewed medical journals. Providers who actively participate in clinical research are generally at the forefront of the fields and aware of the most up-to-date advances in treatments for their patients.

8 Clinical Trials

Leveraging Methylated DNA Markers (MDMs) in the Detection of Endometrial Cancer, Ovarian Cancer, and Cervical Cancer: a Phase II Clinical Study
Leveraging Methylated DNA Markers (MDMs) in the Detection of Endometrial Cancer, Ovarian Cancer, and Cervical Cancer: a Phase II Clinical Study
Enrollment Status: Recruiting
Publish Date: April 17, 2026
Intervention Type: Diagnostic test
A Randomized Phase III Trial of Radiation Therapy and Cisplatin Alone or in Combination With Intravenous Triapine in Women With Newly Diagnosed Bulky Stage IB2, Stage II, IIIB, or IVA Cancer of the Uterine Cervix or Stage II-IVA Vaginal Cancer
A Randomized Phase III Trial of Radiation Therapy and Cisplatin Alone or in Combination With Intravenous Triapine in Women With Newly Diagnosed Bulky Stage IB2, Stage II, IIIB, or IVA Cancer of the Uterine Cervix or Stage II-IVA Vaginal Cancer
Enrollment Status: Active_not_recruiting
Publish Date: August 21, 2026
Intervention Type: Radiation, Drug, Other
Study Drugs: Cisplatin, Triapine
Study Phase: Phase 3
A Phase III Study Comparing Single-Agent Olaparib or the Combination of Cediranib and Olaparib to Standard Platinum-Based Chemotherapy in Women With Recurrent Platinum-Sensitive Ovarian, Fallopian Tube, or Primary Peritoneal Cancer
A Phase III Study Comparing Single-Agent Olaparib or the Combination of Cediranib and Olaparib to Standard Platinum-Based Chemotherapy in Women With Recurrent Platinum-Sensitive Ovarian, Fallopian Tube, or Primary Peritoneal Cancer
Enrollment Status: Active_not_recruiting
Publish Date: July 31, 2026
Intervention Type: Drug, Procedure, Other
Study Drugs: Carboplatin, Cediranib Maleate, Gemcitabine, Gemcitabine Hydrochloride, Olaparib, Paclitaxel, Pegylated Liposomal Doxorubicin Hydrochloride
Study Phase: Phase 3
Phase I Trial of Intravenous Administration of Vesicular Stomatitis Virus Genetically Engineered to Express Thyroidal Sodium Iodide Symporter (NIS) and Human Interferon Beta (hIFNb), in Patients With Metastatic or Recurrent Endometrial Cancer
Phase I Trial of Intravenous Administration of Vesicular Stomatitis Virus Genetically Engineered to Express Thyroidal Sodium Iodide Symporter (NIS) and Human Interferon Beta (hIFNb), in Patients With Metastatic or Recurrent Endometrial Cancer
Enrollment Status: Active_not_recruiting
Publish Date: July 21, 2026
Intervention Type: Procedure, Drug, Biological, Other
Study Phase: Phase 1
WISP (Women Choosing Surgical Prevention)
WISP (Women Choosing Surgical Prevention)
Enrollment Status: Active_not_recruiting
Publish Date: July 15, 2026
Intervention Type: Other, Procedure
Study Phase: Not Applicable
A Randomized Phase II/III Study of the Combination of Cediranib and Olaparib Compared to Cediranib or Olaparib Alone, or Standard of Care Chemotherapy in Women With Recurrent Platinum-Resistant or -Refractory Ovarian, Fallopian Tube, or Primary Peritoneal Cancer (COCOS)
A Randomized Phase II/III Study of the Combination of Cediranib and Olaparib Compared to Cediranib or Olaparib Alone, or Standard of Care Chemotherapy in Women With Recurrent Platinum-Resistant or -Refractory Ovarian, Fallopian Tube, or Primary Peritoneal Cancer (COCOS)
Enrollment Status: Active_not_recruiting
Publish Date: July 01, 2026
Intervention Type: Procedure, Drug, Other
Study Drugs: Cediranib, Cediranib Maleate, Olaparib, Paclitaxel, Pegylated Liposomal Doxorubicin Hydrochloride, Topotecan, Topotecan Hydrochloride
Study Phase: Phase 2/Phase 3
Comparative Analysis of CA-IX, p16, Proliferative Markers, and Human Papilloma Virus (HPV) in the Diagnosis of Significant Cervical Lesions in Patients With a Cytologic Diagnosis of Atypical Glandular Cells (AGC)
Comparative Analysis of CA-IX, p16, Proliferative Markers, and Human Papilloma Virus (HPV) in the Diagnosis of Significant Cervical Lesions in Patients With a Cytologic Diagnosis of Atypical Glandular Cells (AGC)
Enrollment Status: Unknown
Publish Date: May 03, 2024
Intervention Type: Other
Study Phase: Not Applicable
A Randomized Phase II/III Study of Paclitaxel/Carboplatin/Metformin (NSC#91485) Versus Paclitaxel/Carboplatin/Placebo as Initial Therapy for Measurable Stage III or IVA, Stage IVB, or Recurrent Endometrial Cancer
A Randomized Phase II/III Study of Paclitaxel/Carboplatin/Metformin (NSC#91485) Versus Paclitaxel/Carboplatin/Placebo as Initial Therapy for Measurable Stage III or IVA, Stage IVB, or Recurrent Endometrial Cancer
Enrollment Status: Unknown
Publish Date: September 30, 2021
Intervention Type: Other, Drug
Study Drugs: Carboplatin, Metformin hydrochloride, Paclitaxel
Study Phase: Phase 2/Phase 3
View 7 Less Clinical Trials

197 Total Publications

Assessment of Perceptions and Practices in Primary Care Providers Regarding Opportunistic Salpingectomy.
Assessment of Perceptions and Practices in Primary Care Providers Regarding Opportunistic Salpingectomy.
Journal: Journal of primary care & community health
Published: August 12, 2026
Similar Doctors
Expertise in
17
conditions
Dr. Andrea Mariani
Obstetrics and Gynecology
Expertise in
17
conditions
Dr. Andrea Mariani
Obstetrics and Gynecology
Referral may be required

MN - Cancer

200 1st St SW, 
Rochester, MN 
 (0.1 miles away)
507-512-1667
Languages Spoken:
English
See accepted insurances
Accepting New Patients

Andrea Mariani is an Obstetrics and Gynecologist practicing medicine in Rochester, Minnesota. Dr. Mariani is highly rated in 17 conditions, according to our data. His clinical expertise encompasses Endometrial Cancer, Ovarian Cancer, Endometrial Stromal Sarcoma, Lymphadenectomy, and Hysterectomy. Dr. Mariani is currently accepting new patients.

Expertise in
10
conditions
Dr. Carrie L. Langstraat
Obstetrics and Gynecology
Expertise in
10
conditions
Dr. Carrie L. Langstraat
Obstetrics and Gynecology
Referral may be required

MN - Cancer

200 1st St SW, 
Rochester, MN 
 (0.1 miles away)
507-512-1667
Languages Spoken:
English
See accepted insurances
Accepting New Patients
Offers Telehealth

Carrie Langstraat is an Obstetrics and Gynecologist practicing medicine in Rochester, Minnesota. Dr. Langstraat is highly rated in 10 conditions, according to our data. Her clinical expertise encompasses Endometrial Cancer, Ovarian Cancer, Virilizing Ovarian Tumor, Hysterectomy, and Intrauterine Device Insertion. Dr. Langstraat is currently accepting new patients.

Expertise in
7
conditions
Dr. Sean C. Dowdy
Obstetrics and Gynecology
Expertise in
7
conditions
Dr. Sean C. Dowdy
Obstetrics and Gynecology
Referral may be required

MN - Cancer

200 1st St SW, 
Rochester, MN 
 (0.1 miles away)
507-512-1667
Languages Spoken:
English
See accepted insurances
Accepting New Patients

Sean Dowdy is an Obstetrics and Gynecologist practicing medicine in Rochester, Minnesota. Dr. Dowdy is highly rated in 7 conditions, according to our data. His clinical expertise encompasses Endometrial Cancer, Ovarian Cancer, Endometrial Stromal Sarcoma, Lymphadenectomy, and Hysterectomy. Dr. Dowdy is currently accepting new patients.

Frequently Asked Questions about Dr. Jamie N. Bakkum-Gamez

How do I make an appointment with Dr. Jamie N. Bakkum-Gamez?

You can book an appointment with Dr. Jamie N. Bakkum-Gamez by calling their office at 507-512-1667. MediFind provides direct contact information so you can schedule visits, second opinions, or consultations without navigating third-party calendars.

Is Dr. Jamie N. Bakkum-Gamez a top-rated expert for Endometrial Cancer?

MediFind is an objective health platform that identifies experts based on real-world data. Dr. Jamie N. Bakkum-Gamez is classified as an Elite expert for Endometrial Cancer, meaning they are among the top experts in the country for this condition. This ranking is based on their volume of patients, published research, and peer connections.

What conditions does Dr. Jamie N. Bakkum-Gamez specialize in?

While Dr. Jamie N. Bakkum-Gamez is a Obstetrics and Gynecology, they have specific expertise in Endometrial Cancer, Ovarian Cancer, and Hysterectomy. MediFind analyzes a doctor's articles and referral patterns to identify their specific areas of focus within Obstetrics and Gynecology.

Does Dr. Jamie N. Bakkum-Gamez participate in research or clinical trials?

Yes. Dr. Jamie N. Bakkum-Gamez has published 197 articles and abstracts on conditions like Endometrial Cancer. You can view a list of Dr. Jamie N. Bakkum-Gamez's latest peer-reviewed publications and clinical trial participation on their profile to see if they are active in new treatments.

Does Dr. Jamie N. Bakkum-Gamez accept my insurance?

Dr. Jamie N. Bakkum-Gamez accepts most major insurance plans, including Blue Cross Blue Shield and Cigna. We recommend calling the office directly at 507-512-1667 to verify that your specific plan is currently accepted before your visit.

Areas of Expertise

MediFind evaluates expertise by pulling from factors such as number of articles a doctor has published in medical journals, participation in clinical trials, speaking at industry conferences, prescribing and referral patterns, and strength of connections with other experts in their field.

Learn more about MediFind’s expert tiers

Find Dr. Bakkum-Gamez's expertise for a condition
ConditionClose
View All 8 Distinguished Conditions
View All 9 Advanced Conditions
View All 24 Experienced Conditions
Want to save this doctor for later?
Sign Up
Is this your doctor?
Find A Second Opinion
Not sure about your diagnosis?
Check Your Symptoms
 
 
 
 
Learn about our expert tiers
Learn More
Are you the provider on this profile?
Claim Profile